|
1
|
Dickson RB, Gelmann EP, Knabbe C, et al:
Mechanisms of estrogenic and antiestrogenic regulation of growth of
human breast carcinoma. Hormonal Manipulation of Cancer: Peptides,
Growth Factors, and New (Anti) Steroidal Agents. Klijn JGM: Raven
Press; New York, NY: pp. 381–403. 1987
|
|
2
|
Clark GM and McGuire WL: Steroid receptors
and other prognostic factors in primary breast cancer. Semin Oncol.
18:20–25. 1989.
|
|
3
|
Clarke RB, Howell A, Potten CS, et al:
Dissociation between steroid receptor expression and cell
proliferation in the human breast. Cancer Res. 57:4987–4991.
1997.PubMed/NCBI
|
|
4
|
Henderson BE, Pike MC and Ross RK:
Epidemiology and risk factors. Breast Cancer: Diagnosis and
Management. Bonadonna G: John Wiley and Sons Ltd; New York, NY: pp.
1–17. 1984
|
|
5
|
Henderson BE, Ross RK and Pike MC:
Hormonal chemoprevention of cancer in women. Science. 259:633–638.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Perera FP: Environment and cancer: who are
susceptible? Science. 278:1068–1073. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McLachlan JA: Functional toxicology: a new
approach to detect biologically active xenobiotics. Environ Health
Perspect. 101:386–387. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Taylor P: Anticholinesterase agents. The
Pharmacological Basis of Therapeutics. Goodman Gilman A, Rall TW,
Nies AS and Taylor P: Pergamon Press Inc; New York, NY: pp.
131–147. 1990
|
|
9
|
Klaasen C: Nonmetallic environmental
toxicants: air pollutants, solvents and vapors, and pesticides. The
Pharmacological Basis of Therapeutics. Goodman Gilman A, Rall TW,
Nies AS and Taylor P: Pergamon Press Inc; New York, NY: pp.
1615–1635. 1990
|
|
10
|
Silman I and Futerman A: Modes of
attachment of acetylcholinesterase to the surface membrane. Eur J
Biochem. 170:11–20. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krieger N: Rising incidence of breast
cancer. J Natl Cancer Inst. 80:2–3. 1988. View Article : Google Scholar
|
|
12
|
Krieger N: Exposure, susceptibility, and
breast cancer risk: a hypothesis regarding exogenous carcinogens,
breast tissue development, and social gradients, including
black/white differences, in breast cancer incidence. Breast Cancer
Res Treat. 13:205–223. 1989. View Article : Google Scholar
|
|
13
|
Kelsey JL, Gammon MD and John EM:
Reproductive factors and breast cancer. Epidemiol Rev. 15:36–47.
1993.PubMed/NCBI
|
|
14
|
Kelsey JL and Bernstein L: Epidemiology
and prevention of breast cancer. Annu Rev Public Health. 17:47–67.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lippman M, Bolan G and Huff K: The effects
of estrogens and antiestrogens on hormone-responsive human breast
cancer in long-term tissue culture. Cancer Res. 36:4595–4601.
1976.PubMed/NCBI
|
|
16
|
Dickson RB and Lippman ME: Control of
human breast cancer by estrogen, growth factors, and oncogenes.
Cancer Treat Res. 40:119–165. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Key TJ and Pike MC: The dose-effect
relationship between ‘unopposed’ oestrogens and endometrial mitotic
rate: its central role in explaining and predicting endometrial
cancer risk. Br J Cancer. 57:205–212. 1988.
|
|
18
|
Feigelson HS and Henderson BE: Estrogens
and breast cancer. Carcinogenesis. 17:2279–2284. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bernstein L: The epidemiology of breast
cancer. LOWAC J. 1:7–13. 1998.
|
|
20
|
Toniolo PG, Levitz M, Zeleniuch-Jacquotte
A, et al: A prospective study of endogenous estrogens and breast
cancer in postmenopausal women. J Natl Cancer Inst. 87:190–197.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adlercreutz H, Gorbach SL, Goldin BR, et
al: Estrogen metabolism and excretion in Oriental and Caucasian
women. J Natl Cancer Inst. 86:1076–1082. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berrino F, Muti P, Micheli A, et al: Serum
sex hormone levels after menopause and subsequent breast cancer. J
Natl Cancer Inst. 88:291–296. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shimizu H, Ross RK, Bernstein L, et al:
Serum oestrogen levels in postmenopausal women: comparison of
American whites and Japanese in Japan. Br J Cancer. 62:451–453.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bernstein L, Yuan JM, Ross RK, et al:
Serum hormone levels in pre-menopausal Chinese women in Shanghai
and white women in Los Angeles: results from two breast cancer
case-control studies. Cancer Causes Control. 1:51–58. 1990.
View Article : Google Scholar
|
|
25
|
Bernstein L, Ross RK, Pike MC, et al:
Hormone levels in older women: a study of post-menopausal breast
cancer patients and healthy population controls. Br J Cancer.
61:298–302. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kirkman H: Estrogen-induced tumors of the
kidney. III Growth characteristics in the Syrian hamster. Natl
Cancer Inst Monogr. 1:1–57. 1959.PubMed/NCBI
|
|
27
|
Li JJ, Li SA, Klicka JK, et al: Relative
carcinogenic activity of various synthetic and natural estrogens in
the Syrian hamster kidney. Cancer Res. 43:5200–5204.
1983.PubMed/NCBI
|
|
28
|
International Agency for Research on
Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic
Risks to Humans. 21. Scientific Publications, IARC; Lyon: pp.
279–362. 1979
|
|
29
|
International Agency for Research on
Cancer (IARC). IARC Monographs on the Evolution of Carcinogenic
Risks to Humans. IARC; (Suppl 7)Lyon: pp. 280–285. 1987
|
|
30
|
Cavalieri EL, Stack DE, Devanesan PD, et
al: Molecular origin of cancer: catechol estrogen-3,4-quinones as
endogenous tumor initiators. Proc Natl Acad Sci USA.
94:10937–10942. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chakravarti D, Mailander P, Cavalieri E,
et al: Estrogen-DNA damage in mouse skin H-ras gene is mutated by
error prone repair. Proc Am Assoc Cancer Res. 41:1072000.
|
|
32
|
Segaloff A and Maxfield WS: The synergism
between radiation and estrogen in the production of mammary cancer
in the rat. Cancer Res. 31:166–168. 1971.PubMed/NCBI
|
|
33
|
Calaf GM and Garrido F: Catechol estrogens
as biomarkers for mammary gland cancer. Int J Oncol. 39:177–183.
2011.PubMed/NCBI
|
|
34
|
International Agency for Research on
Cancer (IARC). IARC Monographs on the Evolution of Carcinogenic
Risks to Humans. 72. Hormonal Contraception and Postmenopausal
Hormone Therapy. IARC; Lyon: 1999
|
|
35
|
Huseby RA: Demonstration of a direct
carcinogenic effect of estradiol on Leydig cells of the mouse.
Cancer Res. 40:1006–1013. 1980.PubMed/NCBI
|
|
36
|
Highman B, Norwell MJ and Shellenberger
TE: Pathological changes in female C3H mice continuously fed diets
containing diethylstilbestrol or 17beta-estradiol. J Environ Pathol
Toxicol. 1:1–30. 1978.
|
|
37
|
Highman B, Greenman DL, Norvell MJ, Farmer
J and Shellenberger TE: Neoplastic and preneoplastic lesions
induced in female C3H mice by diets containing diethylstilbestrol
or 17beta-estradiol. J Environ Pathol Toxicol. 4:81–95. 1980.
|
|
38
|
Highman B, Roth SI and Greenman DL:
Osseous changes and osteosacomas in mice continuously fed diets
containing diethylstilbestrol or 17beta-estradiol. J Natl Cancer
Inst. 67:653–662. 1981.PubMed/NCBI
|
|
39
|
Nagasawa H, Mori T and Nakajima Y:
Long-term effects of progesterone or diethylstilbestrol with or
without estrogen after maturity on mammary tumorigenesis in mice.
Eur J Cancer. 16:1583–1589. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Inoh A, Kamiya K, Fujii Y and Yokoro K:
Protective effects of progesterone and tamoxifen in
estrogen-induced mammary carcinogenesis in ovariectomized W/Fu
rats. Jpn J Cancer Res. 76:699–704. 1985.PubMed/NCBI
|
|
41
|
Noble RL, Hochachka BC and King D:
Spontaneous and estrogen-produced tumors in Nb rats and their
behavior after transplantation. Cancer Res. 35:766–780.
1975.PubMed/NCBI
|
|
42
|
Shull JD, Spady TJ, Snyder MC, Johansson
SL and Pennington KL: Ovary-intact, but not ovariectomized female
ACI rats treated with 17beta-estradiol rapidly develop mammary
carcinoma. Carcinogenesis. 18:1595–1601. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Welsch CW: Host factors affecting the
growth of carcinogen-induced rat mammary carcinomas: a review and
tribute to Charles Brenton Huggins. Cancer Res. 45:3415–3443.
1985.PubMed/NCBI
|
|
44
|
Li JJ and Li SA: Estrogen-induced
tumorigenesis in hamsters: roles for hormonal and carcinogenic
activities. Arch Toxicol. 55:110–118. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li JJ and Li SA: Estrogen carcinogenesis
in Syrian hamster tissues: role of metabolism. Fed Proc.
46:1858–1863. 1987.PubMed/NCBI
|
|
46
|
Bhat HK, Calaf GM, Hei TK, et al: Critical
role of oxidative stress in estrogen-induced carcinogenesis. Proc
Natl Acad Sci USA. 100:3913–3918. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liehr JG: Genotoxic effects of estrogens.
Mutat Res. 238:269–276. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Institute of Animal Laboratory Resources.
Guide for the Care and Use of Laboratory Animals. National Academy
Press; Washington, DC: 1996
|
|
49
|
Russo J and Russo IH: Mammary
tumorigenesis. Prog Exp Tumor Res. 33:175–191. 1991.
|
|
50
|
Wellings SR, Jensen HM and Marcum RG: An
atlas of subgross pathology of the human breast with special
reference to possible precancerous lesions. J Natl Cancer Inst.
55:231–273. 1975.PubMed/NCBI
|
|
51
|
Cabello G, Valenzuela M, Vilaxa A, et al:
A rat mammary tumor model induced by the organophosphorous
pesticides parathion and malathion, possibly through
acetylcholinesterase inhibition. Environ Health Perspect.
109:471–479. 2001. View Article : Google Scholar
|
|
52
|
Alfaro-Lira S, Pizarro-Ortiz M and Calaf
GM: Malignant transformation of rat kidney induced by environmental
substances and estrogen. Int J Environ Res Public Health. (In
Press).
|
|
53
|
Echiburu-Chau C and Calaf GM: Rat lung
cancer induced by malathion and estrogen. Int J Oncol. 33:603–611.
2008.PubMed/NCBI
|
